African Pharmaceutical Regulatory Intelligence
METHYLPHENIDATE HYDROCHLORIDE
54 registrations across 6 African markets— 38 active
Markets with METHYLPHENIDATE HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Concerta 27mg extended-release tablet Tablet | 🇰🇪Kenya | Janssen Pharmaceuticals, Inc | active | Jul 2031 |
| Concerta 36mg extended-release tablet Tablet | 🇰🇪Kenya | Janssen Pharmaceuticals, Inc | active | Jul 2031 |
| METHYLPHENIDATE HCL-DOUGLAS 10MG TABLETS (Each tablet contains methylphenidate hydrochloride 10mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| METHYLPHENIDATE HCL-DOUGLAS 10MG TABLETS (Each tablet contains methylphenidate hydrochloride 10mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| LINTIRAL | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 2030 |
| PHENITAB 27 | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Sept 2028 |
| PHENITAB 36 | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Sept 2028 |
| PHENITAB 18 | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Sept 2028 |
| PHENITAB 54 | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Sept 2028 |
| ATEROCON LA 30 mg | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | May 2028 |
| ATEROCON LA 40 mg | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | May 2028 |
| ATEROCON LA 20 mg | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | May 2028 |
| ATEROCON LA 60 mg | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | May 2028 |
| CONUFEN 27 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2028 |
| CONUFEN 18 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2028 |
| CONUFEN 36 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2028 |
| CONUFEN 54 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2028 |
| RITALIN TABLET; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMACEUTICAL CORPORATION | active | Dec 2027 |
| Ritalin 10 mg Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2026 |
| METHEYLPHENIDATE 36 SUN | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| NEUTIF 27 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| NEUTIF 18 | 🇿🇦South Africa | Ranbaxy Pharmaceuticals (Pty) Ltd | suspended | Sept 2025 |
| SATEFIN 36 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| METHEYLPHENIDATE 27 SUN | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| SATEFIN 18 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| SATEFIN 27 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| METHEYLPHENIDATE 18 SUN | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| METHEYLPHENIDATE 54 SUN | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| NEUTIF 36 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| NEUTIF 54 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| SATEFIN 54 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Sept 2025 |
| RALITIN 20 | 🇿🇦South Africa | TRIOMED (PTY) LTD | suspended | Dec 2023 |
| RALITIN 5 | 🇿🇦South Africa | TRIOMED (PTY) LTD | suspended | Dec 2023 |
| RALITIN 10 | 🇿🇦South Africa | TRIOMED (PTY) LTD | suspended | Dec 2023 |
| RITALIN 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2011 |
| RITALIN 10 | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Oct 2002 |
| CONTRAMYL XR 54 mg | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| METHYLPHENIDATE HCl - DOUGLAS 10 mg | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | active | Jan 1900 |
| ADAPHEN 10 | 🇿🇦South Africa | TRIOMED (PTY) LTD | active | Jan 1900 |
| NEUCON 18 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| NEUCON 27 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| CONTRAMYL XR 27 mg | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| CONTRAMYL XR 36 mg | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| CONCERTA 18 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| RITALIN LA 30 | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| CONTRAMYL XR 18 mg | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| RITALIN LA 10 | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| NEUCON 54 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| CONCERTA 36 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| CONCERTA 54 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
Showing 50 of 54 registrations. Sign up free to search and export all.
METHYLPHENIDATE HYDROCHLORIDE in Africa — Regulatory Overview
METHYLPHENIDATE HYDROCHLORIDE is registered across 6 African markets with 54 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Kenya, Malawi and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 54 registrations, 38 (70%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.